French, PSG player, Kylian Mbappé holidaying in Morocco
London, Dec. 30, 2020 (AltAfrica)-Kylian Mbappé, the young French international and PSG footballer is currently holidaying in Morocco to rest and celebrate the New Year holiday, 2012
Despite the global coronavirus pandemic, the Paris Saint-Germain (PSG) player chose Marrakech to spend his holidays and give himself the time he needs to unwind and boost his energy before the National Championship and the UEFA Champion League.
Born in 1998 in Paris, Mbappé is considered one of the best players in the world and is known for his clinical finishing, dribbling, strength, and explosive speed.
The French football player made his professional debut in 2015, at the age of 16 with Ligue 1 club Monaco, where he won the title of “Ligue 1 Young Player of the Year” and the Golden Boy award.
Mbappé became the youngest French player to score at a FIFA World Cup in 2018 where he received the Best Young Player and French Player of the Year awards for his performance.
With PSG, Mbappé won three Ligue 1 titles, two Coupe de France titles, finished as Ligue 1 top scorer twice, won Ligue 1 Player of the Year, and is the fourth-highest goalscorer in the club’s history. He is the second-most expensive player and most expensive teenager ever. So far, the 21-year-old has scored 90 goals in his 124 appearances for the French club.
On September 7, Mbappé had to withdraw from the French national team after testing positive for coronavirus. He missed the game against Croatia after being isolated from the rest of the team, the French national team announced.
Morocco is currently preparing for covid-19 mass vaccination. Earlier this month, Morocco’s government announced the purchase of 27 million doses of the Chinese Sinopharma and AstraZeneca/Oxford vaccines.
The government also said that the campaign will be short, not exceeding three months, and aims to vaccinate at least 25 million people. This number amounts to 80% of the Moroccan population, which the government hopes will help achieve herd immunity.